Chaftari AM, Dagher H, Hachem R, Jiang Y, et al. A randomized non-inferiority study comparing imipenem/cilastatin/relebactam with standard-of-care Gram-negative coverage in cancer patients with febrile neutropenia. J Antimicrob Chemother 2024;79:2543-2553.
PMID: 39092963